$ASH 3 SEC Filings

Filed On	Filing
05 Aug 2026	Form 3: Spizzo Allen A, Director No securities owned
05 Aug 2026	Form 3: Thomas Peter T, Director Holds 4,500 shares of Common Stock
18 May 2026	Form 3: Loy Bertrand, Director No securities owned
20 May 2025	Form 3: Richardson Samuel, VP, Controller and PAO Holds 736 shares of Common Stock
19 May 2025	Form 3: Whitaker William, Interim CFO and PFO Holds 1,568 shares of Common Stock
13 Aug 2024	Form 3: Caceres Dago, VP and GM, Specialty Additives No securities owned
13 Jun 2024	Form 3: Assis Alessandra Faccin, SVP and GM, Life Sciences No securities owned
08 May 2024	Form 3: Kulkarni Ashish K, Director No securities owned
17 Apr 2024	Form 3: Tozier Scott, Director No securities owned
14 Nov 2023	Form 3: Chattopadhyay Sanat, Director No securities owned
15 Aug 2023	Form 3: Minicucci James P., SVP Strategy, M&A & Portfolio
15 Aug 2023	Form 3: Bostaph Karl R., SVP Operations Holds 4,866 shares of Common Stock
15 Aug 2023	Form 3: Lampkin Robin E., SVP, Gen. Counsel & Secretary Holds 3,128 shares of Common Stock
06 Jul 2023	Form 3: Pedreiro Sergio, Director No securities owned
01 Jul 2022	Form 3: Bishop Steven D, Director No securities owned
01 Jul 2022	Form 3: Harrison Suzan F., Director No securities owned
02 Dec 2021	Form 3: Drury Eileen, Sr VP, Human Resources
28 Jan 2021	Form 3: Joseph Wetteny, Director No securities owned
11 Jan 2021	Form 3: Winkler von Mohrenfels Petra Yvonne, Sr. VP, GC and Secretary Holds 3,206.154 shares of Common Stock
03 Feb 2020	Form 3: Sandler Ricky C, Director and 1 other Holds 5,635,178 shares of Common Stock, par value $0.01 per share ("Common Stock")

Comments